Region: United Kingdom

UK decision highlights risk surrounding patent enforcement strategies focused on Amazon

The High Court ruling is the country’s first on whether the use of the online platform’s IP procedures can constitute an actionable unjustified threat

11 August 2022

Anti-suit relief may be about to get a second wind in UK FRAND cases

Following a recent decision in a case involving Philips and Oppo, a resurgence in such injunctions could be on the cards

08 August 2022

UK publishes SEP outreach responses, but no changes are imminent

Despite the increasing attraction of the London courts, the real FRAND focus in Europe is likely to be on EU action which is promised by the end of the year

05 August 2022

Brexit was my toughest challenge, says outgoing UK IP Office head

In an exclusive interview, Tim Moss talks through the five years he spent leading the agency and provides an update on its current study of SEP/FRAND policy issues

02 August 2022

Developments at the EPO on patenting AI-assisted inventions require close scrutiny

A recent decision handed down by the Boards of Appeal may mean greater patenting opportunities for innovators using AI to help create their inventions

30 July 2022

UK government blocks IP deal with Chinese company using radical new powers

Recently implemented legislation gives the British government the ability to intervene in IP transactions

22 July 2022

UK government reveals plans to simplify design rights system

Plans to simplify the country’s design system published, following a recent call for views on the existing framework

13 July 2022

Why the UK Apple/Optis dispute is a must-watch for SEP strategists

The country’s third ever FRAND trial decision will build on the global licensing approach laid out in Unwired Planet

12 July 2022

Toyota and Honda ramp up patent filings as wireless technologies become litigation battlefield

London-based firm Mathys & Squire’s research reveals that Japan is the most popular patenting jurisdiction for auto OEMs

08 July 2022

The EU SPC manufacturing waiver transitional period comes to an end

Life sciences companies in Europe are now operating under a regime in which many more patent extension rights are affected by exemptions

05 July 2022

Get unlimited access to all IAM content